Awakn Life Sciences (XCNQ:AWKN) ROCE % : 0.00% (As of Jan. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Awakn Life Sciences's annualized ROCE % for the quarter that ended in Jan. 2024 was 0.00%.

Awakn Life Sciences ROCE % Historical Data

The historical data trend for Awakn Life Sciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences ROCE % Chart

Awakn Life Sciences Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

ROCE %

-188.16

-580.62

-151.86

-1,963.00

Awakn Life Sciences Quarterly Data
	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
ROCE %	Get a 7-Day Free Trial								-212.64	-395.83	-5,765.52	-	-

Awakn Life Sciences ROCE % Calculation

Awakn Life Sciences's annualized ROCE % for the fiscal year that ended in Jan. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jan. 2024 )		(A: Jan. 2023 )		(A: Jan. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jan. 2024 )		(A: Jan. 2023 )		(A: Jan. 2024 )
	=	-3.926	/	( ( (4.394 - 2.463)	+	(0.543 - 2.074) )	/ 2 )
	=	-3.926	/	( (1.931	+	-1.531)	/ 2 )
	=	-3.926	/	0.2
	=	-1,963.00 %

Awakn Life Sciences's ROCE % of for the quarter that ended in Jan. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jan. 2024 )		(Q: Oct. 2023 )		(Q: Jan. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jan. 2024 )		(Q: Oct. 2023 )		(Q: Jan. 2024 )
	=	-3.368	/	( ( (1.091 - 2.039)	+	(0.543 - 2.074) )	/ 2 )
	=	-3.368	/	( ( -0.948	+	-1.531 )	/ 2 )
	=	-3.368	/	-1.2395
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Jan. 2024) EBIT data.

Awakn Life Sciences (XCNQ:AWKN) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Awakn Life Sciences ROCE % Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Awakn Life Sciences (XCNQ:AWKN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (XCNQ:AWKN) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

AWKNF:USA 954:Germany

Address

301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2

Website

https://www.awaknlifesciences.com

Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting the people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences (XCNQ:AWKN) Headlines

No Headlines